Abstract
To date, evidence on optimal anticoagulant options in patients with AF who concurrently have active cancer remains elusive. The objective of this study was To describe anticoagulant patterns among patients with a concomitant diagnosis of AF and cancer and to compare clinical outcomes associated with different anticoagulation strategy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have